Palm Research Center is currently enrolling adult participants in two different type 1 diabetes studies.

Participating in a clinical trial helps to drive scientific progress that will deliver new treatments and therapies to make day-to-day life with T1D easier, safer and healthier. It is part of the Breakthrough T1D mission of curing, preventing, and treating T1D and its complications.

To qualify for either study you must be: 18 years or older, using multiple daily injections (MDI) and have not used a pump within 3 months, and have A1c less than 11%.

Participants will be supplied with diabetic supplies, including insulin, and compensated for their participation. For questions about how to enroll in these opportunities or for more information on Breakthrough T1D sponsored TrialNet research (testing family members at risk for T1D) should contact Palm Research Center at 702-826-2795.